In this issue of Blood, Hengeveld et al describe an openly available, highly sensitive next-generation sequencing approach developed to track minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL).(1) This tool improved patients' outcome prediction in comparison with the traditionally available MRD tools.
机构:
Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USAOhio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USA
Amaral, Anna Cecilia
Hussain, Waleed K.
论文数: 0引用数: 0
h-index: 0
机构:
Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USAOhio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USA
Hussain, Waleed K.
Han, Samuel
论文数: 0引用数: 0
h-index: 0
机构:
Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USA
Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Sect Therapeut Endoscopy, 395 West 12th Ave,2nd Floor,Doan Off Tower, Columbus, OH 43210 USAOhio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH USA